Skip to main content
Clinical Trials/CTRI/2015/02/005511
CTRI/2015/02/005511Not yet recruitingPhase 3

Retinal image acquisition with Brien Holden Visionâ?¢ retinal camera in normal eyes and eyes with diabetic retinopathy and glaucoma - IRC

Australian Government Cooperative Research Centres Program0 sites2,800 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
2,800

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Group I: Healthy participants enrolled in the study must:
  • be male or female aged forty years or over
  • give informed consent;
  • be willing to comply with the clinical study visit schedule as directed by the investigator;
  • have no anterior or posterior segment condition other than refractive error, cataract, pseudophakia or posterior capsular opacification;
  • have vision correctable to at least 6 by12 or better in each eye with spectacles.
  • no visual field defects suggestive of glaucoma on perimetry;
  • Group II: Participants with diabetic retinopathy (DR) enrolled must:
  • be male or female aged 40 years or over
  • give informed consent ;
  • be diagnosed to be Diabetic;
  • be willing to comply with the clinical study visit schedule as directed by the investigator;
  • have eyes classifiable as having no retinopathy, minimal non-proliferative DR, mild- moderate non proliferative DR, severe non-proliferative DR and proliferative DR;
  • have sufficient media clarity for obtaining retinal images.
  • Group III: Participants with glaucoma enrolled must:
  • be male or female aged 40 years or over
  • give informed consent
  • have glaucomatous visual field defects
  • have sufficient media clarity for obtaining retinal images

Exclusion Criteria

  • History of chronic renal failure requiring dialysis or kidney transplant;
  • any active ocular inflammation or infection or evidence of toxoplasmosis or cytomegalovirus or herpes infection of eye;
  • eyes with dilated pupil diameter less than 3mms;
  • In addition, participants with diabetic retinopathy must NOT have
  • Any ocular disease other than DR that may confound diagnosis (exudative AMD, retinal vein occlusion, uveitis, angioid streaks, central serous chorioretinopathy, histoplasmosis, macular hole, retinal detachment, pathological myopia, epiretinal membrane);
  • In addition, participants with glaucoma must NOT have
  • Eyes with field loss attributed to non-glaucoma conditions

Investigators

Sponsor
Australian Government Cooperative Research Centres Program

Similar Trials